Cyclophosphamide was used in this study to define the contribution of the inflammatory response relative to direct cytopathic effects of guinea pig cytomegalovirus (GPCMV) in inducing sensorineural hearing loss in the guinea pig. The eighth nerve compound action potential (CAP) threshold on day 7 after inoculation of GPCMV into the scala tympani was an average of 35 dB greater for control animals than for those that were immunosuppressed with daily intraperitoneal injections of cyclophosphamide (20 mg/kg body weight). The amount of GPCMV antigen in the cochlea, detected immunohistochemically, did not correlate with the CAP threshold. However, the greater the inflammatory response to GPCMV in the cochlea, the higher the CAP threshold and thus the greater the hearing loss. This study demonstrates that the inflammatory response to GPCMV may be more important than direct cytopathic effects of the virus in producing sensorineural hearing loss in GPCMV-induced labyrinthitis.
LarkeRPBWheatleyESaigalSCherneskyMA. Congenital cytomegalovirus infection in an urban Canadian community. J Infect Dis1980; 142: 647–53.
3.
StagnoSPassRFDworskyMEBrittWJAlfordCA. Congenital and perinatal cytomegalovirus infections. Semin Perinatal1983; 7: 31–42.
4.
McCrackenGHShinefieldHRCobbKRausenARDischeREichenwaldHF. Congenital cytomegalic inclusion disease: A longitudinal study of 20 patients. Am J Dis Child1969; 17: 522–39.
5.
HanshawJBDudgeonJA. Congenital cytomegalovirus. In: Viral diseases of the fetus and newborn. Philadelphia, Pa: WB Saunders, 1978: 97–152. (Major problems in clinical pediatrics; vol 17.).
6.
PassRFStagnoSMyersGJAlfordCA. Outcome of symptomatic congenital cytomegalovirus infection: Results of long-term longitudinal follow-up. Pediatrics1980; 66: 758–62.
7.
WilliamsonWDDesmondMMLaFeversNTaberLHCatlinFIWeaverTG. Symptomatic congenital cytomegalovirus. Disorders of language, learning, and hearing. Am J Dis Child1982; 136: 902–5.
8.
StraussMA. A clinical pathologic study of hearing loss in congenital cytomegalovirus infection. Laryngoscope1985; 95: 951–62.
9.
MelishMEHanshawJB. Congenital cytomegalovirus infection: Developmental progress of infants detected by routine screening. Am J Dis Child1973; 126: 190–4.
10.
ReynoldsDWStagnoSStubbsKG. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. N Engl J Med1974; 290: 291–6.
HanshawJBScheinerAPMoxleyAWGaevLAbelVScheinerB. School failure and deafness after “silent” congenital cytomegalovirus infection. N Engl J Med1976; 295: 468–70.
13.
StagnoSReynoldsDWAmosCS. Auditory and visual defects resulting from symptomatic and subclinical cytomegaloviral and Toxoplasma infections. Pediatrics1977; 59: 669–78.
14.
DahleAJMcCollisterFPStagnoSReynoldsDWHoffmanHE. Progressive hearing impairment in children with congenital cytomegalovirus infection. J Speech Hear Disord1979; 44: 220–9.
15.
SaigalSLunykOLarkeRPBCherneskyMA. The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study. Am J Dis Child1982; 136: 896–901.
16.
PappasDG. Hearing impairment and vestibular abnormalities among children with subclinical cytomegalovirus. Ann Otol Rhinol Laryngol1983; 92: 552–7.
DavisLEJohnssonLGKornfeldM. Cytomegalovirus labyrinthitis in an infant: Morphological, virological, and immunofluorescent studies. J Neuropathol Exp Neurol1981; 40: 9–19.
23.
HarrisJPWoolfNKRyanAFButlerDMRichmanDD. Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis1984; 150: 523–30.
24.
WoolfNKHarrisJPRyanAFButlerDMRichmanDD. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: Prevention by systemic immunity. Ann Otol Rhinol Laryngol1985; 94: 350–6.
25.
KeithleyEMWoolfNKHarrisJP. Development of morphological and physiological changes in the cochlea induced by cytomegalovirus. Laryngoscope1989; 99: 409–14.
26.
KeithleyEMSharpPWoolfNKHarrisJP. Temporal sequence of viral antigen expression in the cochlea induced by cytomegalovirus. Acta Otolaryngol (Stockh)1988; 106: 46–54.
27.
HsiungGDChoiYCBiaF. Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection. J Infect Dis1978; 138: 191–6.
28.
BachJFStromTB. The mode of action of immunosuppressive agents. Amsterdam, the Netherlands: Elsevier/North Holland, 1985: 175–239.
29.
WinkelsteinA. Differential effects of immunosuppressants on lymphocyte function. J Clin Invest1973; 52: 2293–9.
30.
WinkelsteinA. Effects of cytotoxic immunosuppressants on tuberculin-sensitive lymphocytes in guinea pigs. J Clin Invest1975; 56: 1587–95.
31.
WinkelsteinA. Effect of immunosuppressive drugs on T and B lymphocytes in guinea pigs. Blood1977; 50: 81–91.
32.
BalowJEHurleyDLFauciAS. Cyclophosphamide suppression of established cell-mediated immunity. J Clin Invest1975; 56: 65–70.
33.
RichmanDDClevelandPHOxmanMN. A rapid enzyme immunofiltration technique using monoclonal antibodies to seronegative herpes simplex virus. J Med Virol1982; 9: 299–305.
34.
RedfieldDCRichmanDDOxmanMNKronenbergLH. Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect Immun1981; 32: 1216–26.
35.
HarrisJPWoolfNKRyanAF. Elaboration of systemic immunity following inner ear immunization. Am J Otolaryngol1985; 6: 148–52.
36.
MimsCABlandenRV. Antiviral activity of immune lymphocytes in lymphocytic choriomeningitis virus infection of mice. Infect Immun1972; 6: 695–8.
37.
NathansonNColeGA. Immunosuppression: A means to assess the role of the immune response in acute virus infections. Fed Proc Fed Am Soc Exp Biol1971; 30: 1822–30.
38.
RookAHFauciAS. Cytotoxic cellular immunity and cytomegalovirus: Lessons from studies of the acquired immunodeficiency syndrome and immunosuppressed allograft recipients. In: GilmoreNWainbergMA, eds. Viral mechanisms of immunosuppression. New York, NY: Alan R Liss, 1985: 159–76.
39.
StagnoSWhitleyRJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med1985; 313: 1270–4.
40.
StagnoSVolanakisJEReynoldsDWStroudRAlfordCA. Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest1977; 60: 838–45.
41.
GehrzRCMarkerSCKnorrSOKalisJMBalfourHHJr.. Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet1977; 2: 844–7.
42.
HarrisJP. Immunobiology of the inner ear: Response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg1983; 91: 18–23.
43.
HarrisJP. Immunobiology of the inner ear: Evidence of local antibody production. Ann Otol Rhinol Laryngol1984; 93: 157–62.
TomiyamaSHarrisJP. The endolymphatic sac: Its importance in inner ear immune responses. Laryngoscope1986; 96: 685–91.
47.
TomiyamaSHarrisJP. The role of the endolymphatic sac in inner ear immunity. Acta Otolaryngol (Stockh)1987; 103: 182–8.
48.
FukudaSKeithleyEMHarrisJP. Experimental cytomegalovirus infection: Viremic spread to the inner ear. Am J Otolaryngol1988; 9: 135–41.
49.
Rask-AndersenHStahleJ. Immunodefence of the inner ear? Lymphocyte — Macrophage interaction in the endolymphatic sac. Acta Otolaryngol (Stockh)1980; 89: 283–94.
50.
HarrisJPDarmstadtGL. Sensorineural hearing loss — Medical therapy. In: GatesGA, ed. Current therapy in otolaryngology–head and neck surgery. Philadelphia, Pa: BC Decker, 1990: 50–6.
51.
WoolfNKOchiJWSilvaEJSharpPHarrisJPRichmanDD. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis. Antimicrob Agents Chemother1988; 32: 865–72.
52.
LebelMHFreijBJSyrogiannopoulosGA. Dexamethasone therapy for bacterial meningitis. N Engl J Med1988; 319: 964–71.
